Efficient multiplication CTL preparation method killing tumors in targeted mode
A high-efficiency proliferation and targeting technology, applied in the direction of blood/immune system cells, vertebrate cells, animal cells, etc., can solve the problems of reducing cell killing activity and high proportion of Treg cells, achieving high-efficiency proliferation, inhibiting transformation, and improving efficiency Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0044] Example 1: Preparation of CTL cells
[0045] 1. Preparation of PBMCs
[0046] Collect 50ml of peripheral blood from tumor patients, centrifuge at 2500rpm (rev / min) for 10min, and suck out the upper layer of plasma for later use. Add 0.9% physiological saline for injection to the blood cells, mix well, and dilute the blood cells. Slowly add the diluted peripheral blood onto the human lymphocyte separation liquid layer with a specific gravity of 1.077, the volume ratio of the two is 1:1. Centrifuge at 600g for 30 min, gently suck out the mononuclear cell layer in the form of white mist, and transfer it to another in a centrifuge tube. Diluted with 0.9% normal saline for injection, 400g, centrifuged for 5min, washed 3 times and centrifuged at low speed to obtain PBMC.
[0047] 2. Mini MACS immunomagnetic bead negative sorting method to remove CD4 + CD25 + Treg cells
[0048] The cells were resuspended in MACS (Magnetic-activated cell sorting, magnetic bead separation...
Embodiment 2
[0068] 1. Preparation of PBMCs
[0069] Collect 50ml of peripheral blood from tumor patients, centrifuge at 2500rpm for 10min, and suck out the upper layer of plasma for later use. Add 0.9% physiological saline for injection to the blood cells, mix well, and dilute the blood cells. Slowly add the diluted peripheral blood onto the human lymphocyte separation liquid layer with a specific gravity of 1.077, the volume ratio of the two is 1:1. Centrifuge at 600g for 30 min, gently suck out the mononuclear cell layer in the form of white mist, and transfer it to another in a centrifuge tube. Diluted with 0.9% normal saline for injection, 400g, centrifuged for 5min, washed 3 times and centrifuged at low speed to obtain PBMC.
[0070] 2. Mini MACS immunomagnetic bead negative sorting method to remove CD4 + CD25 + Treg cells
[0071] Resuspend the cells with MACS buffer, pass through a 100 μm filter to obtain suspended single cells, and adjust the cell density to 5×10 8 / ml. Add...
Embodiment 3
[0088] 1. Preparation of PBMC and 2. Mini MACS immunomagnetic bead negative sorting method to remove CD4 + CD25 + Treg cells adopt the same method as in Example 1;
[0089] 3. Separation of DC cells and T lymphocytes:
[0090] will result in CD3 + , CD4 + , CD8 + , CD14 + Mix the cells, aliquot into 30ml of serum-free AIM-Ⅴ medium, at 37°C, 5% CO by volume 2 After static incubation in the incubator for 2 hours, the suspension cells (ie, T lymphocytes) and adherent cells (ie, DCs) were obtained, and the suspension cells were transferred to a new culture flask.
[0091] 4. Preparation of mature DC cells:
[0092] Add 20 ml of serum-free AIM-Ⅴ medium containing 50 ng / ml GM-CSF and 25 ng / ml IL-4 to the adherent DC cells, place at 37 ° C, and the volume percentage is 5% CO 2 cultured in an incubator for 5 days. On the 6th day, 50 μg / ml of the whole tumor cell antigen of the tumor patient was added. On the 7th day, DC cells loaded with the whole tumor cell antigen were obta...
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com